(Q35582376)

9 August 2017

1 reference

title

Congenital cytomegalovirus infection treatment (English)

1 reference

congenital cytomegalovirus infection

9 August 2017

0 references

0 references

1 reference

Gail J. Demmler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14614375

1 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14614375

1 April 2024

publication date

1 November 2003

1 reference

full work available at URL

9 August 2017

https://journals.lww.com/10.1097/01.inf.0000098639.16767.d2

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000098639.16767.D2

Pediatric Infectious Disease Journal

1 April 2024

published in

1 reference

9 August 2017

volume

22

1 reference

9 August 2017

issue

11

1 reference

9 August 2017

page(s)

1005-1006

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

cites work

1

9

372

Plotkin

1969

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000098639.16767.D2

Experimental use of cytosine arabinoside in congenital cytomegalovirus infection

1 April 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000098639.16767.D2

Cytosine arabinoside in the treatment of congenital cytomegalic inclusion disease

1 April 2024

4

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000098639.16767.D2

Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial

1 April 2024

5

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000098639.16767.D2

Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group.

1 April 2024

6

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000098639.16767.D2

Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

1 April 2024

8

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000098639.16767.D2

Ganciclovir therapy of congenital cytomegalovirus pneumonia

1 April 2024

9

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000098639.16767.D2

Ganciclovir treatment of steroid-associated cytomegalovirus disease in a congenitally infected neonate

1 April 2024

10

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000098639.16767.D2

Severe esophagitis in a newborn infant

1 April 2024

11

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000098639.16767.D2

Ganciclovir therapy of congenital cytomegalovirus disease

1 April 2024

12

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000098639.16767.D2

Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience.

1 April 2024

13

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000098639.16767.D2

Pediatric Infectious Disease Journal

1 April 2024

14

22

504

Michaels

2003

1 reference

https://api.crossref.org/works/10.1097/01.INF.0000098639.16767.D2

1 April 2024

Identifiers

1 reference

9 August 2017

1 reference